Real-World Data Offering from Proscia: Empowering Life Sciences to Advance Precision Medicine Pipelines
recent articles
Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex cloud-based digital...
Paige Lymph Node is recognized by the FDA as a breakthrough device to assist pathologists in the detection of breast cancer metastases in lymph node tissue NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital...
In a new case study from Indica Labs, learn how Nottingham University Hospitals NHS Trust leveraged HALO AP to digitize their pathology service and the resulting benefits and improvements for both patients and staff. CLICK HERE TO READ THE...
In January of this year, in a major regulatory milestone, New York State Department of Health approved a new AI-based digital pathology diagnostic test for breast cancer. The test, developed by PreciseDx, is performed on tumor samples removed...
Proscia: Compliance with global information security management standard strengthens customer trust PHILADELPHIA – October 24, 2023 – Proscia®, a leading provider of digital and computational pathology solutions, has earned ISO 27001...
PathAI: The test allows for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It will be announced at the American College...
